On the other hand, antigen presentation through MHC-class I leads to differentiation of naïve CD8+ T cells into cytotoxic T lymphocytes (CTLs), which are directly able to kill antigen-expressing cancer cells (41). The gene discussed is CD8A; the disease is cancer.